Pfizer Stock: Morgan Stanley Raises Target Amid Strong Earnings
Pfizer’s stock received a boost as Morgan Stanley raised its price target from $32 to $33, reflecting optimism after the ...
Pfizer’s stock received a boost as Morgan Stanley raised its price target from $32 to $33, reflecting optimism after the ...
A UK appeals court dealt a significant blow to Pfizer by upholding Moderna's key mRNA technology patent (EP'949) and confirming ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.